N Engl J Med 341:709717 Rossignol P, Dobre D, McMurray JJ et al (2014) Incidence, determinants, and prognostic significance of hyperkalemia and worsening renal function in patients with heart failure receiving the mineralocorticoid receptor antagonist eplerenone or placebo in addition to optimal medical therapy: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF)
Higher body weight is independently associated with increased reflux risk because abdominal fat places additional pressure on the stomach
Does the semaglutide formulation matter for sex drive
Out of habit, they draw 40 units again
Consider this, back in 2024, Novo Nordisk, maker of Ozempic, had a market cap larger than the entire economy of Denmark, the company's home country
To prevent breakage, wrap vials in protective padding